Loading…

Gleason grading challenges in the diagnosis of prostate adenocarcinoma: experience of a single institution

Gleason score (GS) is an important factor in determining management and outcome of prostate adenocarcinoma. A standard GS scheme was introduced by ISUP 2005 consensus conference, but there is still significant discordance in grading prostate adenocarcinomas among pathologists, especially between gen...

Full description

Saved in:
Bibliographic Details
Published in:Virchows Archiv : an international journal of pathology 2016-02, Vol.468 (2), p.213-218
Main Authors: Chen, Sonja D., Fava, Joseph L., Amin, Ali
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c442t-4c135ed08503281aba4857f2d016de46fba4add5e19c05290a0ae3ae6628279b3
cites cdi_FETCH-LOGICAL-c442t-4c135ed08503281aba4857f2d016de46fba4add5e19c05290a0ae3ae6628279b3
container_end_page 218
container_issue 2
container_start_page 213
container_title Virchows Archiv : an international journal of pathology
container_volume 468
creator Chen, Sonja D.
Fava, Joseph L.
Amin, Ali
description Gleason score (GS) is an important factor in determining management and outcome of prostate adenocarcinoma. A standard GS scheme was introduced by ISUP 2005 consensus conference, but there is still significant discordance in grading prostate adenocarcinomas among pathologists, especially between genitourinary-trained (GU) and non-GU pathologists. All biopsies from outside institutions referred for definitive treatment in our hospital are reviewed by a GU pathologist for confirmation and quality assurance. From 2011 to 2013, 117 consecutive prostate consults were retrieved and compared with the initial outside reports as well as final radical prostatectomy (RP) results. Follow-up prostate specific antigen (PSA) was assessed pre- and post-RP, and the results were analyzed. The overall initial GS was higher for all specimens ( p  = 0.007) especially for the RP cases ( p  = 0.002). Overall, the modal GS on initial diagnosis was GS7(4 + 3) that was downgraded to the modal GS6(3 + 3) upon review. Despite an overall substantial agreement between the non-GU and GU pathologists [ICC = 0.66], GS by GU pathologist had higher correlation with the final GS in the RP specimen [ICC = 0.62] than non-GU pathologist [ICC = 0.48]. GS on all reviewed cases were found to correlate significantly with the pre-operative PSA ( p  = 0.002) but the same was not true for the initial report. A non-GU pathologist is more likely to assign a higher GS than a GU pathologist, with a trend to overcall Gleason pattern 4. Considering the implications on treatment, close attention must be paid to the ISUP 2005 consensus conference recommendations.
doi_str_mv 10.1007/s00428-015-1879-4
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1770873986</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1770873986</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-4c135ed08503281aba4857f2d016de46fba4add5e19c05290a0ae3ae6628279b3</originalsourceid><addsrcrecordid>eNp1kU2LFDEQhoMo7uzqD_AiAS9eWivfaW-y6CoseNFzyCTVsxl6kjHpBv33m2HWRQRPgeSppyr1EvKKwTsGYN43AMntAEwNzJpxkE_IhknBBy7APCUbGKUatGDmgly2tgfgzDL9nFxwrbSQABuyv5nRt5LprvqY8o6GOz_PmHfYaMp0uUMak9_l0lKjZaLHWtriF6Q-Yi7B15ByOfgPFH8dsSbMAU-Yp63LZuyOtqRlXVLJL8izyc8NXz6cV-TH50_fr78Mt99uvl5_vB2ClHwZZGBCYQSrQHDL_NZLq8zEIzAdUeqpX_gYFbIxgOIjePAoPGrNLTfjVlyRt2dvn_Xnim1xh9QCzrPPWNbmmDFgjRit7uibf9B9WWvu050oBsr0Bp1iZyr0z7eKkzvWdPD1t2PgTkG4cxCuB-FOQTjZa14_mNftAeNjxZ_Nd4Cfgdaf-rrrX63_a70HT96TtA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1771057529</pqid></control><display><type>article</type><title>Gleason grading challenges in the diagnosis of prostate adenocarcinoma: experience of a single institution</title><source>Springer Link</source><creator>Chen, Sonja D. ; Fava, Joseph L. ; Amin, Ali</creator><creatorcontrib>Chen, Sonja D. ; Fava, Joseph L. ; Amin, Ali</creatorcontrib><description>Gleason score (GS) is an important factor in determining management and outcome of prostate adenocarcinoma. A standard GS scheme was introduced by ISUP 2005 consensus conference, but there is still significant discordance in grading prostate adenocarcinomas among pathologists, especially between genitourinary-trained (GU) and non-GU pathologists. All biopsies from outside institutions referred for definitive treatment in our hospital are reviewed by a GU pathologist for confirmation and quality assurance. From 2011 to 2013, 117 consecutive prostate consults were retrieved and compared with the initial outside reports as well as final radical prostatectomy (RP) results. Follow-up prostate specific antigen (PSA) was assessed pre- and post-RP, and the results were analyzed. The overall initial GS was higher for all specimens ( p  = 0.007) especially for the RP cases ( p  = 0.002). Overall, the modal GS on initial diagnosis was GS7(4 + 3) that was downgraded to the modal GS6(3 + 3) upon review. Despite an overall substantial agreement between the non-GU and GU pathologists [ICC = 0.66], GS by GU pathologist had higher correlation with the final GS in the RP specimen [ICC = 0.62] than non-GU pathologist [ICC = 0.48]. GS on all reviewed cases were found to correlate significantly with the pre-operative PSA ( p  = 0.002) but the same was not true for the initial report. A non-GU pathologist is more likely to assign a higher GS than a GU pathologist, with a trend to overcall Gleason pattern 4. Considering the implications on treatment, close attention must be paid to the ISUP 2005 consensus conference recommendations.</description><identifier>ISSN: 0945-6317</identifier><identifier>EISSN: 1432-2307</identifier><identifier>DOI: 10.1007/s00428-015-1879-4</identifier><identifier>PMID: 26563400</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Adenocarcinoma - metabolism ; Adenocarcinoma - pathology ; Adenocarcinoma - surgery ; Aged ; Aged, 80 and over ; Biopsy ; Humans ; Male ; Medicine ; Medicine &amp; Public Health ; Middle Aged ; Neoplasm Grading ; Original Article ; Pathology ; Prostate-Specific Antigen - metabolism ; Prostatectomy - methods ; Prostatic Neoplasms - metabolism ; Prostatic Neoplasms - pathology ; Prostatic Neoplasms - surgery ; Quality assurance ; Referral and Consultation</subject><ispartof>Virchows Archiv : an international journal of pathology, 2016-02, Vol.468 (2), p.213-218</ispartof><rights>Springer-Verlag Berlin Heidelberg 2015</rights><rights>Springer-Verlag Berlin Heidelberg 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-4c135ed08503281aba4857f2d016de46fba4add5e19c05290a0ae3ae6628279b3</citedby><cites>FETCH-LOGICAL-c442t-4c135ed08503281aba4857f2d016de46fba4add5e19c05290a0ae3ae6628279b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26563400$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chen, Sonja D.</creatorcontrib><creatorcontrib>Fava, Joseph L.</creatorcontrib><creatorcontrib>Amin, Ali</creatorcontrib><title>Gleason grading challenges in the diagnosis of prostate adenocarcinoma: experience of a single institution</title><title>Virchows Archiv : an international journal of pathology</title><addtitle>Virchows Arch</addtitle><addtitle>Virchows Arch</addtitle><description>Gleason score (GS) is an important factor in determining management and outcome of prostate adenocarcinoma. A standard GS scheme was introduced by ISUP 2005 consensus conference, but there is still significant discordance in grading prostate adenocarcinomas among pathologists, especially between genitourinary-trained (GU) and non-GU pathologists. All biopsies from outside institutions referred for definitive treatment in our hospital are reviewed by a GU pathologist for confirmation and quality assurance. From 2011 to 2013, 117 consecutive prostate consults were retrieved and compared with the initial outside reports as well as final radical prostatectomy (RP) results. Follow-up prostate specific antigen (PSA) was assessed pre- and post-RP, and the results were analyzed. The overall initial GS was higher for all specimens ( p  = 0.007) especially for the RP cases ( p  = 0.002). Overall, the modal GS on initial diagnosis was GS7(4 + 3) that was downgraded to the modal GS6(3 + 3) upon review. Despite an overall substantial agreement between the non-GU and GU pathologists [ICC = 0.66], GS by GU pathologist had higher correlation with the final GS in the RP specimen [ICC = 0.62] than non-GU pathologist [ICC = 0.48]. GS on all reviewed cases were found to correlate significantly with the pre-operative PSA ( p  = 0.002) but the same was not true for the initial report. A non-GU pathologist is more likely to assign a higher GS than a GU pathologist, with a trend to overcall Gleason pattern 4. Considering the implications on treatment, close attention must be paid to the ISUP 2005 consensus conference recommendations.</description><subject>Adenocarcinoma - metabolism</subject><subject>Adenocarcinoma - pathology</subject><subject>Adenocarcinoma - surgery</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biopsy</subject><subject>Humans</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Middle Aged</subject><subject>Neoplasm Grading</subject><subject>Original Article</subject><subject>Pathology</subject><subject>Prostate-Specific Antigen - metabolism</subject><subject>Prostatectomy - methods</subject><subject>Prostatic Neoplasms - metabolism</subject><subject>Prostatic Neoplasms - pathology</subject><subject>Prostatic Neoplasms - surgery</subject><subject>Quality assurance</subject><subject>Referral and Consultation</subject><issn>0945-6317</issn><issn>1432-2307</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp1kU2LFDEQhoMo7uzqD_AiAS9eWivfaW-y6CoseNFzyCTVsxl6kjHpBv33m2HWRQRPgeSppyr1EvKKwTsGYN43AMntAEwNzJpxkE_IhknBBy7APCUbGKUatGDmgly2tgfgzDL9nFxwrbSQABuyv5nRt5LprvqY8o6GOz_PmHfYaMp0uUMak9_l0lKjZaLHWtriF6Q-Yi7B15ByOfgPFH8dsSbMAU-Yp63LZuyOtqRlXVLJL8izyc8NXz6cV-TH50_fr78Mt99uvl5_vB2ClHwZZGBCYQSrQHDL_NZLq8zEIzAdUeqpX_gYFbIxgOIjePAoPGrNLTfjVlyRt2dvn_Xnim1xh9QCzrPPWNbmmDFgjRit7uibf9B9WWvu050oBsr0Bp1iZyr0z7eKkzvWdPD1t2PgTkG4cxCuB-FOQTjZa14_mNftAeNjxZ_Nd4Cfgdaf-rrrX63_a70HT96TtA</recordid><startdate>20160201</startdate><enddate>20160201</enddate><creator>Chen, Sonja D.</creator><creator>Fava, Joseph L.</creator><creator>Amin, Ali</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7T7</scope><scope>7TM</scope><scope>7TO</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>20160201</creationdate><title>Gleason grading challenges in the diagnosis of prostate adenocarcinoma: experience of a single institution</title><author>Chen, Sonja D. ; Fava, Joseph L. ; Amin, Ali</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-4c135ed08503281aba4857f2d016de46fba4add5e19c05290a0ae3ae6628279b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adenocarcinoma - metabolism</topic><topic>Adenocarcinoma - pathology</topic><topic>Adenocarcinoma - surgery</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biopsy</topic><topic>Humans</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Middle Aged</topic><topic>Neoplasm Grading</topic><topic>Original Article</topic><topic>Pathology</topic><topic>Prostate-Specific Antigen - metabolism</topic><topic>Prostatectomy - methods</topic><topic>Prostatic Neoplasms - metabolism</topic><topic>Prostatic Neoplasms - pathology</topic><topic>Prostatic Neoplasms - surgery</topic><topic>Quality assurance</topic><topic>Referral and Consultation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Sonja D.</creatorcontrib><creatorcontrib>Fava, Joseph L.</creatorcontrib><creatorcontrib>Amin, Ali</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing and Allied Health Source</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health Medical collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Biological Sciences</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Biological Science Journals</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Virchows Archiv : an international journal of pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Sonja D.</au><au>Fava, Joseph L.</au><au>Amin, Ali</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Gleason grading challenges in the diagnosis of prostate adenocarcinoma: experience of a single institution</atitle><jtitle>Virchows Archiv : an international journal of pathology</jtitle><stitle>Virchows Arch</stitle><addtitle>Virchows Arch</addtitle><date>2016-02-01</date><risdate>2016</risdate><volume>468</volume><issue>2</issue><spage>213</spage><epage>218</epage><pages>213-218</pages><issn>0945-6317</issn><eissn>1432-2307</eissn><abstract>Gleason score (GS) is an important factor in determining management and outcome of prostate adenocarcinoma. A standard GS scheme was introduced by ISUP 2005 consensus conference, but there is still significant discordance in grading prostate adenocarcinomas among pathologists, especially between genitourinary-trained (GU) and non-GU pathologists. All biopsies from outside institutions referred for definitive treatment in our hospital are reviewed by a GU pathologist for confirmation and quality assurance. From 2011 to 2013, 117 consecutive prostate consults were retrieved and compared with the initial outside reports as well as final radical prostatectomy (RP) results. Follow-up prostate specific antigen (PSA) was assessed pre- and post-RP, and the results were analyzed. The overall initial GS was higher for all specimens ( p  = 0.007) especially for the RP cases ( p  = 0.002). Overall, the modal GS on initial diagnosis was GS7(4 + 3) that was downgraded to the modal GS6(3 + 3) upon review. Despite an overall substantial agreement between the non-GU and GU pathologists [ICC = 0.66], GS by GU pathologist had higher correlation with the final GS in the RP specimen [ICC = 0.62] than non-GU pathologist [ICC = 0.48]. GS on all reviewed cases were found to correlate significantly with the pre-operative PSA ( p  = 0.002) but the same was not true for the initial report. A non-GU pathologist is more likely to assign a higher GS than a GU pathologist, with a trend to overcall Gleason pattern 4. Considering the implications on treatment, close attention must be paid to the ISUP 2005 consensus conference recommendations.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>26563400</pmid><doi>10.1007/s00428-015-1879-4</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0945-6317
ispartof Virchows Archiv : an international journal of pathology, 2016-02, Vol.468 (2), p.213-218
issn 0945-6317
1432-2307
language eng
recordid cdi_proquest_miscellaneous_1770873986
source Springer Link
subjects Adenocarcinoma - metabolism
Adenocarcinoma - pathology
Adenocarcinoma - surgery
Aged
Aged, 80 and over
Biopsy
Humans
Male
Medicine
Medicine & Public Health
Middle Aged
Neoplasm Grading
Original Article
Pathology
Prostate-Specific Antigen - metabolism
Prostatectomy - methods
Prostatic Neoplasms - metabolism
Prostatic Neoplasms - pathology
Prostatic Neoplasms - surgery
Quality assurance
Referral and Consultation
title Gleason grading challenges in the diagnosis of prostate adenocarcinoma: experience of a single institution
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T14%3A11%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Gleason%20grading%20challenges%20in%20the%20diagnosis%20of%20prostate%20adenocarcinoma:%20experience%20of%20a%20single%20institution&rft.jtitle=Virchows%20Archiv%20:%20an%20international%20journal%20of%20pathology&rft.au=Chen,%20Sonja%20D.&rft.date=2016-02-01&rft.volume=468&rft.issue=2&rft.spage=213&rft.epage=218&rft.pages=213-218&rft.issn=0945-6317&rft.eissn=1432-2307&rft_id=info:doi/10.1007/s00428-015-1879-4&rft_dat=%3Cproquest_cross%3E1770873986%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c442t-4c135ed08503281aba4857f2d016de46fba4add5e19c05290a0ae3ae6628279b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1771057529&rft_id=info:pmid/26563400&rfr_iscdi=true